The cannabis market is beginning to swing into full effect now that many countries are beginning to legalize it. Primarily, cannabis is being used to treat medical conditions such as chronic pain, arthritis and even cancer. Although a lack of research is hindering the market, it is still posed for significant growth. According to Verified Market Intelligence, the global cannabis market was valued at USD 42.2 Billion in 2017. The market is also is projected to reach USD 466.81 Billion while growing at a CAGR of 35.3% during the forecast period, from 2018 to 2025. The acceleration of the cannabinoid market is a main driver of the overall cannabis market. Specifically, cannabidiol, or CBD, is seeing a surge of growth due to both the medical and recreational market. Recently, the U.S. Food and Drug Administration removed CBD from the Schedule 1 drug classification, making it the only form of cannabis to be delisted. The FDA’s decision now allows manufacturers to sell a non-synthetic cannabis-derived medicines. CLS Holdings, USA Inc. (OTC:CLSH), Tilray, Inc. (NASDAQ:TLRY), Innovative Industrial Properties, Inc. (NYSE:IIPR), New Age Beverages Corporation (NASDAQ:NBEV), iAnthus Capital Holdings, Inc. (OTC:ITHUF)
The FDA’s decision also opens doors for regulators to look into the cannabis market in general, potentially allowing cannabinol (CBN) and delta-9-tetrahydrocannabinol (THC) to be used for medical purposes. The FDA’s move came a few months after it had approved Epidiolex, a CBD treatment for rare types of epilepsy. Now, a number of countries are beginning to approve the use of the product for therapeutic applications while the use for recreational applications still remain restricted. However, the legalization of CBD use for medical treatments does allow countries to loosen up regulations and ease them towards recreational use. “After more surgeries than I care to admit, my knee was shot, and I was in pain all the time,” said Al Harrington, former NBA player, who also launched his line of CBD products. “If I had the benefit of CBDs… when I was playing, there’s no doubt I could have played two or three more seasons in the NBA.”
CLS Holdings, USA Inc. (OTCQB:CLSH) earlier this month announced breaking news that,
“it has loaned $5 million to In Good Health, a licensed medical dispensary in Brockton, Massachusetts with a significant market share.
CLS continues with its plans and looks forward to the opportunity to enter the rapidly growing Massachusetts market, which has been operating as a legalized medical jurisdiction since 2015 and has approved legalized recreational use.
In Good Health is located 25 miles south of downtown Boston and is one of the 38 licensed dispensaries in the state. The Brockton dispensary was the second licensed dispensary in the state and has been operational since September 2015, which has been medical only up until this time. In Good Health is currently servicing 17,000 registered patients and delivering to 1,700 homes with key product offerings of flower, concentrates, vapes, edibles, pre-rolls and tinctures.
Massachusetts has a population of 6.9 million people as compared to 5.6 million people in Colorado. Massachusetts is also centrally located to the dense population of New England with a less than 100-mile drive from Rhode Island, Connecticut, New York, New Hampshire and Vermont. In 2017, Colorado generated $1.5 billion in legalized marijuana sales and had over 500 licensed dispensaries and over 700 licensed cultivation facilities. Massachusetts currently has issued only 39 licensees.
Jeff Binder, Chief Executive Officer of CLS Holdings USA, commented, “We are pleased to have continued to move forward with In Good Health in a timely manner and are extremely excited to have the opportunity to enter the Massachusetts market. This opportunity fits into our stated objective of entering markets that have attractive characteristics and are on the cusp of implementing a robust adult use market.”
Tilray, Inc. (NASDAQ:TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients in twelve countries spanning five continents. Tilray, Inc. recently reported its financial results for the third quarter and nine months ended September 30th, 2018. Revenue increased to USD 10.0 (CAD 12.9) Million, up 85.8% compared to the third quarter of last year. The increase in revenue was driven by increased patient demand, bulk sales to other Licensed Producers, and accelerated wholesale distribution in export markets. Total kilogram equivalents sold increased over two-fold to 1,613 kilograms from 684 kilograms in the prior year. Average net selling price per gram was USD 6.21 (CAD 7.98) compared to USD 7.53 (CAD 9.34) for the three months ended September 30th, 2017. The reduction in 2018 compared to 2017 was primarily due to an increase in bulk sales as a percentage of total revenue. “The cannabis industry remains very robust and we are pleased with our revenue momentum and strategic achievements in the third quarter,” said Brendan Kennedy, President and Chief Executive Officer of Tilray. “We are in the early stages of achieving our growth potential and our team continues to strategically execute on disciplined operational initiatives and investments to support Tilray’s long-term, sustainable growth as the pace of legalization continues to accelerate around the world. Going forward, the demand for our products is strong and we remain committed to expanding our leadership in the global medical and adult-use cannabis markets.”
Innovative Industrial Properties, Inc. (NYSE:IIPR) is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized industrial properties leased to experienced, state-licensed operators for their regulated medical-use cannabis facilities. Innovative Industrial Properties, Inc. recently announced its results for the quarter ended September 30th, 2018, the seventh full quarter since the Company commenced real estate operations and completed its initial public offering in December 2016. The Company generated total revenues of approximately USD 3.9 MIllion and USD 10.0 Million for the three and nine months ended September 30th, 2018, respectively, and total revenues of approximately USD 1.6 Million and USD 4.1 Million for the three and nine months ended September 30th, 2017, respectively. The increases in both periods were due to the Company’s acquisition of new properties and the annual escalation of base rent for two of the Company’s leases. Base rent under the lease with the PharmaCann subsidiary for one of the Massachusetts properties is abated until November 30th, 2018, and base rent under the lease with GPI at the Michigan property was deferred until November 2th, 2018. Subsequent to the end of the quarter, in October 2018, the Company acquired a 58,000 sq. ft. cannabis cultivation facility in Colorado and entered into a long-term lease with The Green Solution, LLC for USD 11.25 Million.
New Age Beverages Corporation (NASDAQ:NBEV) is a Colorado-based healthy beverage company focused on inspiring, educating, and hydrating consumers. New Age Beverages Corporation recently announced its results for the third quarter ended September 30th, 2018. For the three-month period ended September 30th, 2018, gross revenues reached USD 15.3 Million versus USD 16.8 Million in the prior-year quarter. Net revenues less discounts, returns and billbacks reached USD 13.2 Million versus USD 15.0 Million in the prior-year quarter. The working capital shortfall that prohibited the Company’s ability to meet demand during the majority of the quarter, which negatively impacted revenue between USD 5.8 Million and USD 6.2 Million. Brent Willis, Chief Executive Officer of New Age mentioned, “New Age continued to progress its strategy to become the world’s leading healthy beverage company in Q3. We significantly strengthened the Company’s balance sheet and cash position. Now, with the distribution breadth of our core brands and our ability to fulfill demand, the impending launch of our CBD portfolio, and next steps with strategic growth opportunities, we are confident in our ability to continue to drive excellent return for shareowners.”
iAnthus Capital Holdings, Inc. (OTCQX:ITHUF) owns and operates best-in-class licensed cannabis cultivation, processing and dispensary facilities throughout the United States, providing investors diversified exposure to the U.S. regulated cannabis industry. iAnthus Capital Holdings, Inc., and MPX Bioceutical Corporation recently announced that both companies have signed an arrangement agreement pursuant to which iAnthus will combine with MPX in an all-stock transaction with offered equity consideration to MPX shareholders valued at USD 835 Million before giving effect to MPX International and assuming all of MPX’s dilutive securities are exercised prior to the completion of the transaction. The Agreement represents the first public to public merger transaction in U.S. cannabis history. The combined company, excluding MPX International, will encompass operations and cannabis licenses in 10 states that will permit iAnthus to operate 56 retail locations and 14 cultivation/processing facilities. As a result of the transaction, iAnthus will add retail and/or production capabilities in Arizona, Maryland, Nevada, California and Massachusetts. These additional licenses complement iAnthus’ existing assets in New York, Florida, Massachusetts, Vermont, Colorado, and New Mexico, forming super-regional footprints in both the eastern and western United States. “This is a watershed moment for iAnthus, as we nearly double the size of our national footprint in the United States. iAnthus will be uniquely positioned for success on the U.S. East Coast, while solidifying our cultivation and retail presence with the additions of California, Nevada, Maryland and Arizona,” said Hadley Ford, Chief Executive Officer of iAnthus. “Since its inception, iAnthus has been strategically focused on building scale, and this announcement crystallizes our positioning as one of the largest multi-state operators in North America.”
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Media Contact:email@example.com +1-877-601-1879